[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335273-105":59,"doc-detail-335273-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-epigenetic-biomarkers-for-hematopoietic-cancer-found-in-twins-research-time-to-event-and-matched-case-cotwin-ewas","Novel epigenetic biomarkers for hematopoietic cancer found in twins - Research - time-to-event and matched case-cotwin EWAS","","This article identifies epigenetic markers associated with hematopoietic malignancies using an epigenome-wide association study of DNA methylation. A register-based matched case-cotwin design analyzes 1,085 Danish twins with 31 malignancies and methylation levels from 450,154 CpG sites. Associations are tested with time-to-event regression, enhancing control for unmeasured shared confounding and reducing false discoveries. In results, 67 epigenetic markers are detected, including 12 linked to hematologic malignancy genes, and risk differs 2–3-fold by methylation levels. Predictive models reach 92% cross-validated AUC and validate with a Harrell’s C of 73%.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-epigenetic-biomarkers-for-hematopoietic-cancer-found-in-twins-research-time-to-event-and-matched-case-cotwin-ewas/335273/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-epigenetic-biomarkers-for-hematopoietic-cancer-found-in-twins-research-time-to-event-and-matched-case-cotwin-ewas/335273.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study aim to identify about hematopoietic cancers?","Question",{"text":112,"@type":113},"It aims to identify epigenetic markers and detect early development of hematopoietic malignancies using DNA methylation data from an epigenome-wide association study.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the matched case-cotwin design contribute to the analysis?",{"text":117,"@type":113},"One twin with malignancy is compared with their cotwin without malignancy, controlling for unmeasured shared confounding such as shared genes and shared childhood environment.",{"name":119,"@type":110,"acceptedAnswer":120},"What predictive performance did the study report, and how was it validated?",{"text":121,"@type":113},"A cross-validated, time-varying model showed a 92% area under the curve 3 years after blood sampling, with performance above 70% up to 6 years. Validation in an independent Older Finnish Twin Cohort yielded an overall Harrell’s C of 73%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335273,1790216997,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","ORIGINAL ARTICLE  \nNovel epigenetic biomarkers for hematopoietic cancer found in twins  \nSigne B. Clemmensena,b, Henrik Frederiksenc,d, Jonas Mengel-Froma,b,e, Aino Heikkinenf, Jaakko Kapriof and Jacob vB. Hjelmborga,b  \na Department of Epidemiology, Biostatistics, and Biodemography, Institute of Public Health, University of Southern Denmark, Odense, Denmark; bDanish Twin Registry, Institute of Public Health, University of Southern Denmark, Odense, Denmark; c Department of Haematology, Odense University Hospital, Odense, Denmark; dDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark; eDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark; fInstitute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Helsinki, Finland  \nABSTRACT  \nBackground and purpose: This article aims to identify epigenetic markers and detect early development of hematopoietic malignancies through an epigenome wide association study of DNA methylation data. Materials and methods: This register-based study includes 1,085 Danish twins with 31 hematopoietic malignancies and methylation levels from 450,154 5’-C-phospate-G-3’(CpG) sites. Associations between methylation levels and incidence of hematopoietic malignancy is studied through time-to-event regression. The matched case-cotwin design, where one twin has a malignancy and the cotwin does not, is applied to enhance control for unmeasured shared confounding and false discoveries. Predictive performance is validated in the independent Older Finnish Twin Cohort.  \nResults and interpretation: We identified 67 epigenetic markers for hematopoietic malignancies of which 12 are linked to genes associated with hematologic malignancies. For some markers, we discovered a 2–3-fold relative risk difference for high versus low methylation. The identification of these 67 sites enabled the formation of a predictor demonstrating a cross-validated time-varying area under the curve (AUC) of 92%  \n3 years after individual blood sampling and persistent performance above 70% up to 6 years after blood sampling. This predictive performance was to a large extent recovered in the validation sample showing an overall Harrell’s C of 73% .  \nIn conclusion, from a large population representative twin study on hematopoietic cancers, novel epigenetic markers were identified that may prove useful for early diagnosis.  \nARTICLE HISTORY  \nReceived 2 May 2024 Accepted 30 August 2024 Published 18 September 2024  \nKEYWORDS  \nDNA methylation; EWAS; hematopoietic malignancy; survival analysis; twin study; heritability; FinnGen  \nIntroduction  \nHematopoietic malignancies are cancers of the blood and blood-forming organs. They constitute 8–10% of all cancers diagnosed in the Nordic countries between 2017 and 2021 [1, 2] . In recent years, many contributions have been made to improve diagnostics and treatment. The ability to detect hematopoietic malignancy through blood samples instead of more invasive biopsies holds great promise to improve early diagnosis of patients. It is already used to some extent as blood cell type composition can provide information on abnormal levels which is seen in patients with leukaemia.  \nA recent study of hematologic malignancies in twins from four Nordic countries found that genetic influence on variation in cancer liability was moderate, which prompted a search for environmental factors [3] . Epigenetic studies can provide the link between environmental exposures and the effect they have on our genes. More specifically, epigenetic modifications governing gene expression, mainly DNA methylation and  \nhistone modification, have been found to play a central role in the understanding of tumour cell development [4]. For instance, a recent study found that DNA methylation is crucial for transdifferentiation of pre-B-acute lymphoblastic leukaemia cells into functional macrophages [5] . Another study proposed a model using peripheral blood DNA methylation","cbCaiseGUPN6P1si","https://ap.wps.com/l/cbCaiseGUPN6P1si","pdf",670414,"English","# Background and purpose\n# Materials and methods\n# Results and interpretation\n# Predictive performance and validation\n# Conclusion\n# Introduction","[{\"question\":\"What does the study aim to identify about hematopoietic cancers?\",\"answer\":\"It aims to identify epigenetic markers and detect early development of hematopoietic malignancies using DNA methylation data from an epigenome-wide association study.\"},{\"question\":\"How does the matched case-cotwin design contribute to the analysis?\",\"answer\":\"One twin with malignancy is compared with their cotwin without malignancy, controlling for unmeasured shared confounding such as shared genes and shared childhood environment.\"},{\"question\":\"What predictive performance did the study report, and how was it validated?\",\"answer\":\"A cross-validated, time-varying model showed a 92% area under the curve 3 years after blood sampling, with performance above 70% up to 6 years. Validation in an independent Older Finnish Twin Cohort yielded an overall Harrell’s C of 73%.\"}]","Novel epigenetic biomarkers for hematopoietic cancer found in twins - Research - time-to-event and matched case-cotwin EWAS | PDF",1790010357]